Literature DB >> 1705699

Cyclic-AMP-dependent phosphorylation modulates the stereospecific activation of cardiac Ca channels by Bay K 8644.

F Tiaho1, S Richard, P Lory, J M Nerbonne, J Nargeot.   

Abstract

Voltage-gated Ca channels have been reported to be regulated by membrane potential, phosphorylation and binding of specific agonists or antagonists such as dihydropyridines. We report here evidence that cyclic AMP (cAMP) modulates the activation of Ca-channel current by the dihydropyridine agonist Bay K 8644. Bay K 8644 (racemate) alone induces a primary voltage-dependent, potentiating effect on peak current amplitude and accelerates the current decay. In contrast, in the presence of cAMP activators, we observed a striking slowing of the decay in addition to the increase in peak current. The agonist (-)-Bay K 8644, but not the antagonist (+)-Bay K 8644, when applied in combination with cAMP, forskolin or isoproterenol, mimics the effect of the racemate. We have interpreted the results presented here in respect of a cAMP-dependent modulation of Bay K 8644 effects on cardiac Ca-channel currents. It may open the new perspective that dephosphorylated and phosphorylated Ca channels have distinct pharmacology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705699     DOI: 10.1007/bf00370769

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  34 in total

1.  Inactivation of calcium channels in mammalian heart cells: joint dependence on membrane potential and intracellular calcium.

Authors:  K S Lee; E Marban; R W Tsien
Journal:  J Physiol       Date:  1985-07       Impact factor: 5.182

2.  Calcium current in isolated neonatal rat ventricular myocytes.

Authors:  N M Cohen; W J Lederer
Journal:  J Physiol       Date:  1987-10       Impact factor: 5.182

3.  Beta-adrenergic increase in the calcium conductance of cardiac myocytes studied with the patch clamp.

Authors:  G Brum; W Osterrieder; W Trautwein
Journal:  Pflugers Arch       Date:  1984-06       Impact factor: 3.657

4.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.

Authors:  K S Lee; R W Tsien
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

7.  Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.

Authors:  S Kokubun; H Reuter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Calcium channel selectivity for divalent and monovalent cations. Voltage and concentration dependence of single channel current in ventricular heart cells.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  J Gen Physiol       Date:  1986-09       Impact factor: 4.086

9.  Voltage-dependent modulation of Ca channel current in heart cells by Bay K8644.

Authors:  M C Sanguinetti; D S Krafte; R S Kass
Journal:  J Gen Physiol       Date:  1986-09       Impact factor: 4.086

10.  Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines.

Authors:  A E Lacerda; A M Brown
Journal:  J Gen Physiol       Date:  1989-06       Impact factor: 4.086

View more
  15 in total

1.  Reduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation.

Authors:  Xiongwen Chen; Xiaoying Zhang; David M Harris; Valentino Piacentino; Remus M Berretta; Kenneth B Margulies; Steven R Houser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

2.  Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence.

Authors:  J Zeng; Y Rudy
Journal:  Biophys J       Date:  1995-03       Impact factor: 4.033

3.  Voltage-dependent regulation of L-type cardiac Ca channels by isoproterenol.

Authors:  F Tiaho; J Nargeot; S Richard
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

4.  L-type Ca2+ channel responses to bay k 8644 in stem cell-derived cardiomyocytes are unusually dependent on holding potential and charge carrier.

Authors:  Junzhi Ji; Jiesheng Kang; David Rampe
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738

5.  Differential beta-adrenergic regulation and phenotypic modulation of voltage-gated calcium currents in rat aortic myocytes.

Authors:  D Neveu; J F Quignard; A Fernandez; S Richard; J Nargeot
Journal:  J Physiol       Date:  1994-09-01       Impact factor: 5.182

6.  Inactivation of the Ba2+ current in dissociated Helix neurons: voltage dependence and the role of phosphorylation.

Authors:  J L Yakel
Journal:  Pflugers Arch       Date:  1992-04       Impact factor: 3.657

7.  Cyclic AMP-dependent regulation of P-type calcium channels expressed in Xenopus oocytes.

Authors:  F Fournier; E Bourinet; J Nargeot; P Charnet
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

8.  Regulation of the frequency-dependent facilitation of L-type Ca2+ currents in rat ventricular myocytes.

Authors:  F Tiaho; C Piot; J Nargeot; S Richard
Journal:  J Physiol       Date:  1994-06-01       Impact factor: 5.182

9.  Modulation of L-type Ca channel activity by P2-purinergic agonist in cardiac cells.

Authors:  F Scamps; B Nilius; J Alvarez; G Vassort
Journal:  Pflugers Arch       Date:  1993-02       Impact factor: 3.657

10.  "Caged" phenylephrine: development and application to probe the mechanism of alpha-receptor-mediated vasoconstriction.

Authors:  S Muralidharan; G M Maher; W A Boyle; J M Nerbonne
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.